This month on The BloodStream Podcast, Nabila Husseni from Gujarat, India shares her story of living with Factor V deficiency and championing women’s equality, Natalie presents a recent NBC story on the rise of depression, we discuss Takeda’s acquisition of Shire, and Hope For Hemophilia founder Jonathan James joins us for the Interview Segment. All that and more on Episode 24 of The BloodStream Podcast!
Exclusive Sponsor: Shire
Latest Ask The Expert Podcast: Episode 14 - Physical Therapy
Latest Powering Through Podcast: Episode 16 - HANY's Family Education Conference
Like Segment: Major depression on the rise among everyone, new data shows
Share Segment: Nabila Husseni- Strength
Comment Segment: Japan's Takeda clinches $62 billion Shire Deal
Interview Segment: Hope for Hemophilia
Community News in 60 Seconds:
Hemlibra Named a Breakthrough Therapy for Hemophilia A Without Inhibitors
On World Hemophilia Day, Bioverativ Shares Success Stories from the Developing World
CRISPR “One Shot" Cell Therapy for Hemophilia Developed
Gene-Editing Study in Monkeys Sets Stage for Further HIV Cure Research
Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study
Hemophilia therapy could be first drug with $1M price tag: 3 things to know
Seattle Plans to Build an AIDS Memorial Called The AMP
BloodFeed:
Connect with BloodStream:
Email mailbag@bloodstreammedia.com
Find all of our bleeding disorders podcasts on BloodStreamMedia.com
Subscribe to BloodStream:
iTunes: http://bit.ly/bloodstreamitunes
Stitcher: http://bit.ly/bloodstreamstitcher
LibSyn: http://bit.ly/bloodstreamlibsyn
SoundCloud: http://bit.ly/bloodstreamSC
TuneIn: http://bit.ly/bloodstreamtunein
Google Play: http://bit.ly/bloodstreamPlay
Spotify: http://spoti.fi/2nNPhui